REGENIX DRUGS LIMITED
Summary
REGENIX DRUGS LIMITED is registered in India and entered in the “Companies Register (Ministry of Corporate Affairs)” under number U24232TN2007PLC063446. Its legal form is Public Limited Company (Ltd). REGENIX DRUGS LIMITED is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 17 Oct 2022 and the record was last updated on 20 Aug 2025; the next renewal is due by 16 Oct 2026.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Public Limited Company (Ltd) |
|---|---|
| Register | Companies Register (Ministry of Corporate Affairs) · Register website |
| Registration number | U24232TN2007PLC063446 |
| Registration authority | Ministry of Corporate Affairs |
| Jurisdiction | India |
| Registered address | JAMAL SONU TERRACE, 42/1 LOGANATHAN NAGAR FIRST STREET, 100 FEET ROAD, CHOOLAIMEDU,, 600094 CHENNAI, India |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 9 May 2007 |
| LEI | 335800K7RCRWTWHY2O57 |
| LEI status | active |
| LEI first issued | 17 Oct 2022 |
| LEI record last updated | 20 Aug 2025 |
| Next LEI renewal | 16 Oct 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
- Ultimate parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
Direct subsidiaries (1)
- REGENIX BIOSCIENCES LIMITED India · CHENNAI